DE3030323A1 - Die verwendung von imidazolderivaten als spermatostatika oder spermizide - Google Patents

Die verwendung von imidazolderivaten als spermatostatika oder spermizide

Info

Publication number
DE3030323A1
DE3030323A1 DE19803030323 DE3030323A DE3030323A1 DE 3030323 A1 DE3030323 A1 DE 3030323A1 DE 19803030323 DE19803030323 DE 19803030323 DE 3030323 A DE3030323 A DE 3030323A DE 3030323 A1 DE3030323 A1 DE 3030323A1
Authority
DE
Germany
Prior art keywords
imidazole
oxalate
group
substituted phenyl
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE19803030323
Other languages
German (de)
English (en)
Other versions
DE3030323C2 (https=
Inventor
Duane W. Hallesy
Richard E. Palo Alto Calif. Jones
Brian H. Cupertino Calif. Vickery
Keith A.M. Los Altos Hills Calif. Walker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syntex USA LLC
Original Assignee
Syntex USA LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex USA LLC filed Critical Syntex USA LLC
Priority to DE19803030323 priority Critical patent/DE3030323A1/de
Publication of DE3030323A1 publication Critical patent/DE3030323A1/de
Application granted granted Critical
Publication of DE3030323C2 publication Critical patent/DE3030323C2/de
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19803030323 1980-08-11 1980-08-11 Die verwendung von imidazolderivaten als spermatostatika oder spermizide Granted DE3030323A1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE19803030323 DE3030323A1 (de) 1980-08-11 1980-08-11 Die verwendung von imidazolderivaten als spermatostatika oder spermizide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19803030323 DE3030323A1 (de) 1980-08-11 1980-08-11 Die verwendung von imidazolderivaten als spermatostatika oder spermizide

Publications (2)

Publication Number Publication Date
DE3030323A1 true DE3030323A1 (de) 1982-03-11
DE3030323C2 DE3030323C2 (https=) 1990-07-12

Family

ID=6109367

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19803030323 Granted DE3030323A1 (de) 1980-08-11 1980-08-11 Die verwendung von imidazolderivaten als spermatostatika oder spermizide

Country Status (1)

Country Link
DE (1) DE3030323A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0070525A3 (en) * 1981-07-22 1984-01-11 Toko Yakuhin Industry Co., Ltd. Pharmaceutical preparations for external use

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4078071A (en) * 1976-03-08 1978-03-07 Syntex (U.S.A.) Inc. Derivatives of substituted N-alkyl imidazoles

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4078071A (en) * 1976-03-08 1978-03-07 Syntex (U.S.A.) Inc. Derivatives of substituted N-alkyl imidazoles

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0070525A3 (en) * 1981-07-22 1984-01-11 Toko Yakuhin Industry Co., Ltd. Pharmaceutical preparations for external use

Also Published As

Publication number Publication date
DE3030323C2 (https=) 1990-07-12

Similar Documents

Publication Publication Date Title
DE69725345T2 (de) Verwendung von 5-ht4 antagonisten zur überwindung der gastrointestinalen beschädigung, die durch inhibitoren der serotonin-wiederaufnahme hervorgerufen werden
DE69107215T2 (de) (2-imidazolin-2-ylamino)chinoxalinderivate und methoden in ihrer anwendung.
DE102005008310A1 (de) Verwendung von CDKII Inhibitoren zur Fertilitätskontrolle
DE69007471T2 (de) Verfahren zur verhütung oder zur begrenzung einer reperfusionsschädigung.
DE3446371A1 (de) 5-pyrimidincarboxamide und 5-pyrimidinthiocarboxamide und ihre verwendung zur behandlung von leukaemie und tumoren
DE69229688T4 (de) Ophthalmische Zusammensetzungen, die Kombinationen von einem Carboanhydrase-Inhibitor und einem Beta-adrenergischen Antagonist enthalten
EP0928192B1 (de) Antimykotisches gel mit hoher wirkstofffreisetzung
DE69630465T2 (de) Vorsorge-/heilmittel fur die komplikationen von diabetes
EP1196159B1 (de) Verwendung von tosylchloramid(en) zur behandlung von erkrankungen der haut, der schleimhaut, von organen und geweben
DE3031703C2 (https=)
DE3030323A1 (de) Die verwendung von imidazolderivaten als spermatostatika oder spermizide
EP0471388B1 (de) Mittel zur Behandlung der Herzinsuffizienz
EP1834640A2 (de) Kappa-Opiatagonisten für die Behandlung von Erkrankungen der Blase
DE3500756A1 (de) Verwendung von chinolonen zur behandlung der herzinsuffizienz
DE2166662C3 (de) Dibenzothiazepinderivate, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
DE2605243A1 (de) Pyrazolessigsaeurehaltiges arzneimittel
DE69214647T2 (de) Verwendung von atipamezol zur behandlung der männlichen sexuellen impotenz
JPH0234924B2 (ja) Imidazoorujudotaiofukumuhininnyuyonasoseibutsu
DE2842091A1 (de) Verfahren zur inaktivierung behuellter viren
DE2810052A1 (de) Aminoaryl-1,2,4-triazine, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE2440378A1 (de) Arzneimittel mit antiphlogistischen und analgetischen eigenschaften
DE2551591A1 (de) 4-(4-diphenylyl)-butylamine und pharmazeutische zusammensetzungen
DE1967186C3 (de) Arzneimittel, enthaltend 4,4-Diarylpiperidine
AT360665B (de) Verfahren zur herstellung neuer hetero- cyclischer verbindungen
DE1645999A1 (de) 1-substituierte 5-Aminotetrazole sowie die Behandlung des tierischen Organismus mit diesen Verbindungen

Legal Events

Date Code Title Description
8101 Request for examination as to novelty
8105 Search report available
8110 Request for examination paragraph 44
8128 New person/name/address of the agent

Representative=s name: DANNENBERG, G., DIPL.-ING., 6000 FRANKFURT WEINHOL

D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee